Related references
Note: Only part of the references are listed.High serum neurofilament levels among Chinese patients with aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders
Chunxin Liu et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2021)
Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer's
Fanny M. Elahi et al.
ALZHEIMERS & DEMENTIA (2020)
Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity
Heidi Hogel et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Can CSF biomarkers predict future MS disease activity and severity?
Roberta Magliozzi et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Inflammation-related plasma and CSF biomarkers for sclerosis
Jesse Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease
Hyunjin Kim et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
A Score Based on NfL and Glial Markers May Differentiate Between Relapsing-Remitting and Progressive MS Course
Andre Huss et al.
FRONTIERS IN NEUROLOGY (2020)
Neurofilament light as a biomarker in traumatic brain injury
Pashtun Shahim et al.
NEUROLOGY (2020)
Time course and diagnostic utility of NfL, tau, GFAP, and UCH-L1 in subacute and chronic TBI
Pashtun Shahim et al.
NEUROLOGY (2020)
Cerebrospinal Fluid Biomarkers in Relation to MRZ Reaction Status in Primary Progressive Multiple Sclerosis
Tilman Robinson et al.
CELLS (2020)
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
Jens Kuhle et al.
NEUROLOGY (2019)
Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD
Mitsuru Watanabe et al.
NEUROLOGY (2019)
Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis
Christian Barro et al.
BRAIN (2018)
Multiple Sclerosis
Daniel S. Reich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Role of Astrocytes in Multiple Sclerosis
Gerald Ponath et al.
FRONTIERS IN IMMUNOLOGY (2018)
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein
Lenka Novakova et al.
NEUROLOGY (2017)
Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases
Mehtap Bacioglu et al.
NEURON (2016)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis
M. Alba Mane Martinez et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Glial but not axonal protein biomarkers as a new supportive diagnostic criteria for Devic neuromyelitis optica? Preliminary results on 188 patients with different neurological diseases
A. Petzold et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)
Share Paper
